Literature DB >> 10639678

Pelvic inflammatory disease after tubal sterilization: a review.

M Levgur1, R Duvivier.   

Abstract

Exceptions ot the common notion that tubal occlusion protects from recurrent pelvic inflammatory disease (PID) do exist. Since 1975, 71 cases of salpingitis and 38 tubo-ovarian abscesses (TOA) in sterilized women have been published. The majority of cases of salpingitis after previous tubal occlusion (SPOT) developed more than a year after either laparoscopic or laparotomy sterilization procedures. For tubo-ovarian abscess after previous tubal occlusion (TOAPOT), this time interval ranged from several weeks to almost two decades. Most cases of salpingitis showed inflammation of both tubal segments. When only one segment was involved, it was generally the proximal segment. The appearance of the TOAPOT at the time of surgery was typical to TOA. The symptoms of salpingitis were not different from symptoms in any other case of PID, and those associated with TOAPOT were typical of TOA. Laboratory findings included leucocytosis and growth of Neisseria gonorrohoea and Chlamydia trachomatis from the cervix, the infected tube, and the peritoneal fluid. Pus cultures obtained from cases of TOAPOT grew mixed or single organisms. Detailed histopathologic studies in tubal specimens after the failure of an occlusion procedure are available from cases with no infection. They have demonstrated distortion, loss of musculature, and loss of lumen configuration, all of which may have been the result of compromised blood supply to the tube. These findings may be extrapolated to cases of SPOT and TOAPOT, assuming similar changes may be present before the development of infection. The mechanisms by which infection may develop in previously occluded tubes are divided into three groups: The first group consists of situations where there is persistence of free passage between the proximal and distal portions of the tube. These include toboperitoneal fistula, spontaneous anastomosis at the occlusion site, recanalization of the occluded site, incomplete tubal occlusion due to a faulty surgical technique or rupture of the weakened tubal wall. The second group consists of infections initiated by the surgical procedure itself, such as introduction of pathogens at surgery, exacerbation of chronic PID, and ascending infection secondary to surgical manipulation. In the third group, the infection is initiated systemically by hematogeneous spread, lymphatic spread, or change in immunologic status.

Entities:  

Mesh:

Year:  2000        PMID: 10639678     DOI: 10.1097/00006254-200001000-00022

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  5 in total

Review 1.  Antichlamydial antibodies, human fertility, and pregnancy wastage.

Authors:  Amanda J Stephens; Mira Aubuchon; Danny J Schust
Journal:  Infect Dis Obstet Gynecol       Date:  2011-09-22

2.  Screening for Chlamydia trachomatis in Egyptian women with unexplained infertility, comparing real-time PCR techniques to standard serology tests: case control study.

Authors:  Rana M A Abdella; Hatem I Abdelmoaty; Rasha H Elsherif; Ahmed Mahmoud Sayed; Nadine Alaa Sherif; Hisham M Gouda; Ahmed El Lithy; Maged Almohamady; Mostafa Abdelbar; Ahmed Naguib Hosni; Ahmed Magdy; Youssef Ma
Journal:  BMC Womens Health       Date:  2015-06-02       Impact factor: 2.809

3.  Colorectal cancer presenting as tuboovarian abscess in a 40 year old patient with previous tubal occlusion.

Authors:  Joy Anderson; Clyde Ellis; Jonathan Lugo
Journal:  Case Rep Womens Health       Date:  2015-11-25

4.  Post-partum, post-sterilization tubo-ovarian abscess caused by Fusobacterium necrophorum: a case report.

Authors:  Chenchit Chayachinda; Amornrut Leelaporn; Pornpimol Ruangvutilert; Manopchai Thamkhantho
Journal:  J Med Case Rep       Date:  2012-10-02

Review 5.  Non-neoplastic diseases of the fallopian tube: MR imaging with emphasis on diffusion-weighted imaging.

Authors:  Pietro Valerio Foti; Noemi Ognibene; Saveria Spadola; Rosario Caltabiano; Renato Farina; Stefano Palmucci; Pietro Milone; Giovanni Carlo Ettorre
Journal:  Insights Imaging       Date:  2016-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.